Investigation of Endogenous Compounds Applicable to Drug–Drug Interaction Studies Involving the Renal Organic Anion Transporters, OAT1 and OAT3, in Humans-Reference-Cited by-同舟云学术

Investigation of Endogenous Compounds Applicable to Drug–Drug Interaction Studies Involving the Renal Organic Anion Transporters, OAT1 and OAT3, in Humans

Published:2016-09-16 Issue:12 Volume:44 Page:1925-1933
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Tsuruya Yuri,Kato Koji,Sano Yamato,Imamura Yuichiro,Maeda Kazuya,Kumagai Yuji,Sugiyama Yuichi,Kusuhara Hiroyuki

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference44 articles.

1. Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump;Akita;Biochim Biophys Acta,2001

2. The profile of bile acids and their sulfate metabolites in human urine and serum;Bathena;J Chromatogr B Analyt Technol Biomed Life Sci,2013

3. OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin

4. Evaluation of Cynomolgus Monkeys for the Identification of Endogenous Biomarkers for Hepatic Transporter Inhibition and as a Translatable Model to Predict Pharmacokinetic Interactions with Statins in Humans

5. Urinary Excretion of Bile Acids in Cholestasis: Evidence for Renal Tubular Secretion in Man

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Biomarkers for Renal Transporter‐Mediated Drug–Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans;Clinical Pharmacology & Therapeutics;2024-08-15

2. Expanding Role of Endogenous Biomarkers for Assessment of Transporter Activity in Drug Development: Current Applications and Future Horizon;Pharmaceutics;2024-06-25

3. Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective;Clinical Pharmacokinetics;2024-06

4. Inception and Development of a LC–MS/MS Assay for the Multiplexed Quantitation of Nine Human Drug Transporter Biomarkers;Bioanalysis;2024-03

5. Identification and characterization of an endogenous biomarker of the renal vectorial transport (OCT2‐MATE1);Biopharmaceutics & Drug Disposition;2024-02